NIH consensus development statement on management of hepatitis B

NIH consensus and state-of-the-science statements

Volumn 25, Issue 2, 2008, Pages 1-29

  Belongia, E A ^a   Costa, J ^a   Gareen, I F ^a   Grem, J L ^a   Inadomi, J M ^a   Kern, E R ^a   McHugh, J A ^a   Petersen, G M ^a   Rein, M F ^a   Sorrell, M F ^a   Strader, D B ^a   Trotter, H T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

BLOOD; CARCINOMA, HEPATOCELLULAR; CONSENSUS DEVELOPMENT; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; NEEDS ASSESSMENT; PATHOGENICITY; PATIENT SELECTION; PUBLIC HEALTH; RESEARCH; RISK FACTOR; VIROLOGY;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; NEEDS ASSESSMENT; PATIENT SELECTION; PUBLIC HEALTH; RESEARCH; RISK FACTORS;

EID: 84925548039     PISSN: None     EISSN: 15530779     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)